GRAIL Inc (GRAL)
16.06
+0.14
(+0.88%)
USD |
NASDAQ |
Nov 14, 11:41
GRAIL Enterprise Value: -464.54M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 13, 2024 | -464.54M |
November 12, 2024 | -490.31M |
November 11, 2024 | -483.79M |
November 08, 2024 | -509.25M |
November 07, 2024 | -496.21M |
November 06, 2024 | -529.75M |
November 05, 2024 | -526.95M |
November 04, 2024 | -524.78M |
November 01, 2024 | -538.13M |
October 31, 2024 | -537.51M |
October 30, 2024 | -535.96M |
October 29, 2024 | -555.52M |
October 28, 2024 | -557.07M |
October 25, 2024 | -555.21M |
October 24, 2024 | -555.83M |
October 23, 2024 | -534.09M |
October 22, 2024 | -515.77M |
October 21, 2024 | -508.94M |
October 18, 2024 | -500.56M |
October 17, 2024 | -517.95M |
October 16, 2024 | -514.22M |
October 15, 2024 | -523.85M |
October 14, 2024 | -528.19M |
October 11, 2024 | -508.94M |
October 10, 2024 | -554.28M |
Date | Value |
---|---|
October 09, 2024 | -557.38M |
October 08, 2024 | -555.21M |
October 07, 2024 | -561.42M |
October 04, 2024 | -554.28M |
October 03, 2024 | -568.56M |
October 02, 2024 | -547.44M |
October 01, 2024 | -547.44M |
September 30, 2024 | -531.61M |
September 27, 2024 | -511.74M |
September 26, 2024 | -536.58M |
September 25, 2024 | -553.34M |
September 24, 2024 | -547.75M |
September 23, 2024 | -553.96M |
September 20, 2024 | -525.71M |
September 19, 2024 | -528.19M |
September 18, 2024 | -526.95M |
September 17, 2024 | -522.92M |
September 16, 2024 | -522.61M |
September 13, 2024 | -521.36M |
September 12, 2024 | -538.13M |
September 11, 2024 | -545.27M |
September 10, 2024 | -542.48M |
September 09, 2024 | -544.65M |
September 06, 2024 | -564.83M |
September 05, 2024 | -540.61M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-568.56M
Minimum
Oct 03 2024
-342.15M
Maximum
Jun 20 2024
-498.30M
Average
-506.46M
Median
Jul 11 2024
Enterprise Value Benchmarks
Fonar Corp | 35.98M |
XWELL Inc | -1.011M |
ProPhase Labs Inc | 26.50M |
Applied DNA Sciences Inc | -8.746M |
Veracyte Inc | 2.789B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.585B |
Revenue (Quarterly) | 31.97M |
Total Expenses (Quarterly) | 252.32M |
EPS Diluted (Quarterly) | -51.06 |
Gross Profit Margin (Quarterly) | -56.03% |
Profit Margin (Quarterly) | -4.96K% |
Earnings Yield | -428.9% |
Normalized Earnings Yield | -153.16 |